Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionInhibitor of interleukin-1 (IL-1) alpha and IL-1 beta
Molecular Target Interleukin-1 (IL-1) alpha ; Interleukin-1 (IL-1) beta
Mechanism of ActionInterleukin-1 (IL-1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationOsteoarthritis
Indication DetailsTreat osteoarthritis (OA) of the knee
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today